Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD)
49.11
+0.41 (0.84%)
Anheuser-Busch InBev S.A. is a global beverage and brewing company known for its extensive portfolio of iconic beer brands
With roots spanning multiple continents, the company combines the heritage of its founding breweries with modern brewing techniques to produce a diverse range of alcoholic and non-alcoholic beverages. Anheuser-Busch InBev operates numerous breweries and distribution facilities worldwide, focusing on sustainable practices and innovation in product development. Through its commitment to quality and consumer engagement, the company strives to enhance the drinking experience for consumers while also contributing positively to the communities it serves.
Donald Trump placing tariffs on Canada, China and Mexico could impact multiple sectors. A look at the areas where Americans could see higher prices soon.
Shares of major alcohol producers and distributors declined sharply following a warning issued by U.S. Surgeon General Vivek Murthy about the increased cancer risks associated with alcohol consumption.
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Constellation Brands (NYSESTZ) and its peers.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol and tobacco industry, including Anheuser-Busch (NYSEBUD) and its peers.
Key Takeaways: Budweiser APAC’s profit fell 15% in the first nine months of the year as its revenue in China fell 16.1% in the third quarter The mainstream beer maker’s efforts to develop higher-end products may be meeting with headwinds from increasingly cautious Chinese consumer By Lau Chi Hang
Beer powerhouse Anheuser-Busch InBev (NYSEBUD) missed Wall Street’s revenue expectations in Q3 CY2024, with sales falling 3.4% year on year to $15.05 billion. Its non-GAAP profit of $0.98 per share was 7.5% above analysts’ consensus estimates.
The Fed's preferred inflation gauge, the PCE Price Index, rose 2.2% YoY, below expectations. Decline in overall inflation suggests an easing of price pressures.
Our Conservative Cannabis Stocks Portfolio has outperformed our Canadian Cannabis LP Stocks Portfolio by more than a 3 to 1 margin on an annual basis. As such, our conservative cannabis portfolio is just that - a conservative cannabis investment.
If you are wary of the volatility of cannabis stocks then consider the 5 tobacco, beer, and distiller/vintner companies that have major investments in the cannabis sector. Their stock returns outperformed both our MSO and LP cannabis portfolios.
